The company has captured 510(k) clearance for artificial intelligence-based software that facilitates brain and prostate image interpretations.
Siemens Healthineers announced Wednesday it has secured 510(k) clearance from the U.S. Food and Drug Administration for two new artificial intelligence-based software assistants to assist with MRI scans.
These tools will be added to the company’s AI-Rad Companion suite of products, officials said. The AI-Rad Companion Brain MR for Morphometry Analysis segments brain MRI images, measuring brain volume and calculating volume deviations. Additionally, the AI-Rad Companion Prostate MR for Biopsy Support automatically segments prostate MRI images, allowing radiologists to easily mark lesions and facilitate targeted prostate biopsies.
“These new AI-Rad Companion applications for MR exams in the brain and prostate regions will help physicians manage their workloads and achieve a patient-focused decision-making process to increase efficiency and improve the quality of care,” said Peter Shen, vice president of innovation and digital business at Siemens Healthineers North America.
According to company details, the Brain MR product supports brain volumetry with measuring and determining volume changes in gray matter, white matter, and cerebrospinal fluid in the approximately 30 segments of the brain. Previously, radiologists have performed segmentation and comparisons manually or semi-automanually, but this AI-Rad product sends results to a report where deviations from normal levels are automatically flagged. Being able to recognize these changes is clinically important, they said, because reduced volume can point to Parkinson’s disease, Alzheimer’s disease, or other types of dementia.
The Prostate MR tool also automatically segments the prostate, marking the organ’s outer contour in only a few seconds versus the several minutes it takes to do so manually, according to company information. The radiologist marks the suspicious area and sends an annotated MRI report to the urologist that can be fused with ultrasound images during biopsy. Together, these exams can help the urologist identify significant prostate carcinomas.
Both software assistants are DICOM-compliant and can be used with Siemens Healthineers MRI scanners, as well as outside manufacturers. They are available on Siemens’ teamplay cloud-based digital health platform and can be easily be integrated into an existing clinical workflow.
AI Algorithm Comparable to Radiologists in Differentiating Small Renal Masses on CT
May 14th 2024An emerging deep learning algorithm had a lower AUC and sensitivity than urological radiologists for differentiating between small renal masses on computed tomography (CT) scans but had a 21 percent higher sensitivity rate than non-urological radiologists, according to new research.
Appealing Prior Authorization Denials: Can it be Effective for Emerging Technologies?
May 14th 2024While radiologists and other providers may be discouraged by insurer denials saying the use of a technological advance is “unproven and investigational,” 82 percent of appeals for prior authorization denials were approved in 2021.
ACR Collaborative Model Achieves 20 Percent Improvement in PI-QUAL Scores for Prostate MRI
May 9th 2024Using a learning network model to discuss challenges and share insights among radiology departments from five different organizations, researchers noted that 87 percent of audited prostate MRI exams had PI-QUAL scores > 4 at the conclusion of the collaborative program.
MRI-Based Deep Learning Algorithm Shows Comparable Detection of csPCa to Radiologists
May 8th 2024In a study involving over 1,000 visible prostate lesions on biparametric MRI, a deep learning algorithm detected 96 percent of clinically significant prostate cancer (csPCa) in comparison to a 98 percent detection rate for an expert genitourinary radiologist.